Omar Khwaja

Omar Khwaja is an experienced medical professional and drug developer who currently serves as the Chief Medical Officer at VectivBio AG, a clinical-stage biotechnology company focused on developing treatments for rare diseases.12

Professional Background

Dr. Khwaja has over two decades of experience in drug development, medicine, and academia.1 His career highlights include:

• Chief Medical Officer and Head of Research & Development at Voyager Therapeutics, a biotechnology company focused on severe neurological diseases12
• Global Head of Rare Diseases and Neuroscience Translational Medicine at Roche, where he worked for over eight years12
• Director of the Clinical Neurogenetics program at Boston Children's Hospital12
• Faculty member at Harvard Medical School12

Specializations

Dr. Khwaja is a pediatric neurologist with specialized skills in:

• Critical care
• Fetal-neonatal neurology
• Neurogenetics
• Clinical-translational research related to diseases of the developing brain and rare diseases4

Education and Qualifications

• M.D. and Ph.D. in Human Molecular Genetics from the University of Cambridge12
• Member of the Royal College of Physicians12
• Member of the Royal College of Paediatrics and Child Health34

Current Roles

In addition to his position at VectivBio AG, Dr. Khwaja also serves as:

• Chief Medical Officer for the Spinal Muscular Atrophy Foundation12
• Chair of the Scientific Advisory Board of the CDKL5 Forum12

Dr. Khwaja's extensive experience in rare diseases and drug development makes him well-suited for his role at VectivBio AG, where he is involved in developing innovative treatments for severe rare conditions with high unmet medical needs.12